» Articles » PMID: 12819036

Acute Tubular Injury Causes Dysregulation of Cellular Cholesterol Transport Proteins

Overview
Journal Am J Pathol
Publisher Elsevier
Specialty Pathology
Date 2003 Jun 24
PMID 12819036
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Acute renal injury causes accumulation of free and esterified cholesterol (FC, CE) in proximal tubules, mediated, at least in part, by increased cholesterol synthesis. Normally, this would trigger compensatory mechanisms such as increased efflux and decreased influx to limit or reverse the cholesterol overload state. This study sought to determine the integrity of these compensatory pathways following acute renal damage. Rhabdomyolysis-induced acute renal failure was induced in mice by glycerol injection. Normal mice served as controls. After 18 hours, BUN levels and renal cortical FC/CE content were determined. Expression of ABCA-1 and SR-B1 (cholesterol efflux proteins) were assessed by Western blot. Renal cortical LDL receptor (LDL-R; a cholesterol importer) regulation was gauged by quantifying its mRNA. To obtain proximal tubule cell-specific data, the impact of oxidant (Fe) stress on cultured HK-2 cell LDL-R, SR-B1, and ABCA-1 proteins and their mRNAs (versus controls) was assessed. Glycerol evoked marked azotemia and striking FC/CE increments (44%, 384%, respectively). Paradoxically, renal cortical SR-B1 and ABCA-1 protein reductions and LDL-R mRNA increments resulted. Fe-induced injury suppressed HK-2 cell SR-B1, ABCA-1, and their mRNAs. LDL-R protein rose with the in vitro Fe challenge. Renal tubular cell injury causes dysregulation of SR-B1, ABCA-1, and LDL-R protein expression, changes which should contribute to a cholesterol overload state. Reductions in HK-2 cell SR-B1 and ABCA-1 mRNAs and increases in renal cortical LDL-R mRNA imply that this dysregulation reflects, at least in part, altered genomic/transcriptional events.

Citing Articles

Effects of Psychotropic Medication on Somatic Sterol Biosynthesis of Adult Mice.

Balog M, Anderson A, Heffer M, Korade Z, Mirnics K Biomolecules. 2022; 12(10).

PMID: 36291744 PMC: 9599595. DOI: 10.3390/biom12101535.


Intrarenal arteriosclerosis and telomere attrition associate with dysregulation of the cholesterol pathway.

De Vusser K, Winckelmans E, Martens D, Lerut E, Kuypers D, Nawrot T Aging (Albany NY). 2020; 12(9):7830-7847.

PMID: 32353828 PMC: 7244056. DOI: 10.18632/aging.103098.


Metabolic effects of RUBCN/Rubicon deficiency in kidney proximal tubular epithelial cells.

Matsuda J, Takahashi A, Takabatake Y, Sakai S, Minami S, Yamamoto T Autophagy. 2020; 16(10):1889-1904.

PMID: 31944172 PMC: 8386605. DOI: 10.1080/15548627.2020.1712107.


The role of CD47 in pathogenesis and treatment of renal ischemia reperfusion injury.

Isenberg J, Roberts D Pediatr Nephrol. 2018; 34(12):2479-2494.

PMID: 30392076 PMC: 6677644. DOI: 10.1007/s00467-018-4123-z.


Anthocyanins inhibit high-glucose-induced cholesterol accumulation and inflammation by activating LXRα pathway in HK-2 cells.

Du C, Shi Y, Ren Y, Wu H, Yao F, Wei J Drug Des Devel Ther. 2015; 9:5099-113.

PMID: 26379423 PMC: 4567235. DOI: 10.2147/DDDT.S90201.


References
1.
Zager R, Johnson A, Hanson S, dela Rosa V . Altered cholesterol localization and caveolin expression during the evolution of acute renal failure. Kidney Int. 2002; 61(5):1674-83. DOI: 10.1046/j.1523-1755.2002.00316.x. View

2.
Imachi H, Murao K, Sato M, Hosokawa H, Ishida T, Takahara J . CD36 LIMPII analogous-1, a human homolog of the rodent scavenger receptor B1, provides the cholesterol ester for steroidogenesis in adrenocortical cells. Metabolism. 1999; 48(5):627-30. DOI: 10.1016/s0026-0495(99)90061-6. View

3.
Connelly M, Stoudt G, Christian A, Haynes M, Williams D, Rothblat G . Expression of scavenger receptor BI in COS-7 cells alters cholesterol content and distribution. Biochemistry. 2000; 39(1):221-9. DOI: 10.1021/bi991666c. View

4.
Li H, Appelbaum F, Willman C, Zager R, Banker D . Cholesterol-modulating agents kill acute myeloid leukemia cells and sensitize them to therapeutics by blocking adaptive cholesterol responses. Blood. 2002; 101(9):3628-34. DOI: 10.1182/blood-2002-07-2283. View

5.
Acton S, Rigotti A, Landschulz K, Xu S, Hobbs H, Krieger M . Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science. 1996; 271(5248):518-20. DOI: 10.1126/science.271.5248.518. View